Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03797326 |
|---|---|
| Brief Title: | Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) |
| First Submitted : | January 7, 2019 |
| First Submitted that Met QC Criteria : | January 7, 2019 |
| First Posted : | January 9, 2019 |
| Last Update Submitted that Met QC Criteria : | November 11, 2021 |
| Last Update Posted : | November 12, 2021 |